|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/17 | (2015.01) |
| G01N 33/5011 | (2013.01) | ||
| G01N 33/574 | (2006.01) | ||
| G01N 33/505 | (2013.01) | ||
| G01N 33/57492 | (2013.01) | ||
| G01N2800/52 | (2013.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 35/17 | (2013.01) |
| (11) | Number of the document | 4039260 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22153621.2 |
| Date of filing the European patent application | 2018-02-06 | |
| (97) | Date of publication of the European application | 2022-08-10 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 2017020685 | 2017-02-07 | JP | |
| 2017110069 | 2017-06-02 | JP |
| (72) |
KAGAMU, Hiroshi , JP
|
| (73) |
Saitama Medical University ,
38, Morohongo Moroyama-machi, Iruma-gun, Saitama 350-0495,
JP
|
| (54) | CD62LLOW CD4+ T-CELLS FOR TREATING OR PREVENTING CANCER |
| CD62LLOW CD4+ T-CELLS FOR TREATING OR PREVENTING CANCER |